miR-1306 Promotes Lung Squamous Cell Carcinoma Progression and Predicts Clinical Prognosis of Patients

PURPOSE: Lung squamous cell carcinoma (LUSC) is one of the major subtypes of non-small cell lung cancer (NSCLC) with high mortality. Identification of novel biomarkers of the development of LUSC could provide basis for clinical treatment and improve patients’ prognosis. The function of miR-1306 in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Mei, Xu, Chunxiang, Wang, Yan, Liu, Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666722/
https://www.ncbi.nlm.nih.gov/pubmed/34916847
http://dx.doi.org/10.2147/CMAR.S339292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666722/
https://www.ncbi.nlm.nih.gov/pubmed/34916847
http://dx.doi.org/10.2147/CMAR.S339292

Ejemplares similares